Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant

3Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Survivors of hematopoietic cell transplant (HCT) are at risk for neurocognitive impairments, which can negatively affect quality of life. Given limited studies, we aimed to describe the neurocognitive outcomes in a cohort of long-term adult HCT survivors. Eligible survivors (age $21 years at HCT and alive $2 years following HCT) completed a 60-question survey of neurocognitive function and quality of life, which included the Neuro-Quality of Life Cognitive Function Short Form (Neuro-QoL) and the Childhood Cancer Survivor Study Neurocognitive Questionnaire (NCQ). Analyses of risk factors included univariate comparisons and multivariable logistic regression. Survivors (n 5 1861, 47.7% female, 65.6% allogeneic HCT) were surveyed at a median age of 64.2 years (interquartile range [IQR], 56.8-70.5) and a median 12.0 years (IQR, 6.0-21.0) from HCT. Survivors reported average Neuro-QoL scores (50.0 allogeneic; 49.2 autologous survivors) compared with an expected mean of 50 in the general population. On the NCQ, 17.4% to 31.2% of survivors reported impairments (Z-score .1.28) in task efficiency, memory, emotional regulation, or organization, compared with an expected 10% in the general population (all P, .01). In multivariable regression analyses, impaired Neuro-QoL (T-score,40) was independently associated with hearing issues (odds ratio [OR], 2.13; 95% confidence interval [CI], 1.46-3.10) and sleep impairment (OR, 4.41; 95% CI, 2.80-6.94) among allogeneic survivors, with comparable associations in autologous survivors. Overall, long-term adult HCT survivors reported average cognitive quality of life compared with the general population. Subsets of survivors with hearing issues and sleep impairments were more likely to report lower quality of life and impaired neurocognitive function, which may facilitate targeted monitoring or interventions following HCT.

References Powered by Scopus

Review of inverse probability weighting for dealing with missing data

1111Citations
N/AReaders
Get full text

The Impact of Age on Cognition

903Citations
N/AReaders
Get full text

Development of Short Forms From the PROMIS™ Sleep Disturbance and Sleep-Related Impairment Item Banks

807Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Primary central nervous system lymphoma

40Citations
N/AReaders
Get full text

Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States A Cost-Effectiveness Analysis

4Citations
N/AReaders
Get full text

Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample—The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wu, N. L., Phipps, A. I., Krull, K. R., Syrjala, K. L., Carpenter, P. A., Connelly-Smith, L. S., … Chow, E. J. (2022). Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant. Blood Advances, 6(14), 4347–4356. https://doi.org/10.1182/bloodadvances.2021006672

Readers' Seniority

Tooltip

Professor / Associate Prof. 1

50%

Lecturer / Post doc 1

50%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 3

43%

Medicine and Dentistry 2

29%

Nursing and Health Professions 1

14%

Psychology 1

14%

Save time finding and organizing research with Mendeley

Sign up for free